Mallia Aims to Revolutionize Hair Growth with sCD83 at HairS'25

Mallia Aesthetics, a pioneer in cosmetic innovations, is set to spotlight its cutting-edge sCD83-based hair growth approach at the 24th International Hair Science Symposium (HairS’25). As a Gold Sponsor, Mallia enhances its influence at the convergence of scientific research and cosmetic development.

Professor Alexander Steinkasserer, co-founder of Mallia, will present novel findings on sCD83’s potential to combat hair loss. The research indicates that sCD83 creates an anti-inflammatory environment at hair follicles, prevents cell death, and activates stem cells, promoting hair growth and thickness. Recently granted a European patent, sCD83 demonstrates therapeutic prospects in dermatology and wound healing.

Mallia's first commercial sCD83-based product is slated for release by the end of 2025, highlighting the company's strategic strides in innovative cosmetic solutions.